Area of research
Molecular Biology · Immunology
Research interest
Research interests include Immune cells in cancer, RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques, and MicroRNA in disease regulation.
Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway
Peptide Aptamer-Enabled Nanoplasmonic Digital Immunoassay for Ultrasensitive Cytokine Sensing in Early Inflammation and Immune Modulation
Multifunctional Superparamagnetic Copper Iron Oxide Nanoparticles for Synergistic Cancer Therapy via Magnetic Hyperthermia, Oxidative Stress and Immune Reprogramming
A nanoplasmonic cell-on-a-chip for in situ monitoring of PD-L1+ exosome-mediated immune modulation
Amikacin Coated 3D-Printed Metal Devices for Prevention of Postsurgical Infections (PSIs)
Injectable PLGA-based In Situ Forming Subconjunctival Implant for Sustained Ocular Delivery of Ketotifen Fumarate: Formulation, Drug Release, and Biocompatibility Studies
Abstract 4612: Development of an Integrated Microfluidic Chip for CAR T-Cell Therapy: A Preclinical Trial-on-Chip Tool
Novel Disulfiram-Loaded Metal–Organic Nanoparticles Inhibit Tumor Growth and Induce Immunogenic Cell Death of Triple-Negative Breast Cancer Cells
Comparative Formulation and Physicochemical Evaluation of Orodispersible Films Fabricated via Pneumatic and Syringe-Based 3D Printing
Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress
Nanotechnology in Advancing Chimeric Antigen Receptor T Cell Therapy for Cancer Treatment
Long-Acting Drug Delivery Technologies for Meloxicam as a Pain Medicine
S2Map: a novel computational platform for identifying secretio-types through cell secretion-signal map
Amelioration of the Rheumatoid Arthritis Microenvironment Using Celastrol-Loaded Silver-Modified Ceria Nanoparticles for Enhanced Treatment
Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems
Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy
Targeting Wnt/β-catenin signaling using XAV939 nanoparticles in tumor microenvironment-conditioned macrophages promote immunogenicity
Targeting β-catenin using XAV939 nanoparticle promotes immunogenic cell death and suppresses conjunctival melanoma progression
Liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian Cancer Growth
3D-Printed Capsaicin-Loaded Injectable Implants for Targeted Delivery in Obese Patients
Activation of liver X receptors suppresses the abundance and osteoclastogenic potential of osteoclast precursors and periodontal bone loss
Information on the primers for qPCR, and the ESI-MS spectrum of DQ (366.17 m/z)
β-catenin inhibition in tumor microenvironment macrophages promotes immunogenicity
Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein
Near-infrared light triggered activation of pro-drug combination cancer therapy and induction of immunogenic cell death
Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery
BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR<sup>T790M</sup> mutation
Nano-Structural Effects on Gene Transfection: Large, Botryoid-Shaped Nanoparticles Enhance DNA Delivery via Macropinocytosis and Effective Dissociation
Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy
Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFR<sup>T790M</sup>‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery